•
Sep 30, 2018

Jazz Pharmaceuticals Q3 2018 Earnings Report

Total Revenue
$469M
Previous year: $412M
+14.0%
EPS
$3.58
Previous year: $3.22
+11.2%
Gross Profit
$443M
Previous year: $381M
+16.3%
Cash and Equivalents
$499M
Previous year: $253M
+97.5%
Total Assets
$5.49B
Previous year: $5B
+9.7%

Jazz Pharmaceuticals

Jazz Pharmaceuticals